Listed

Standard Biotools Inc.

LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31

Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Standard Biotools Inc., Reports and events
FiledFormWhat it isAccession number
2020-05-0716:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-003481
2020-05-0716:10 ET8-K5.02 Departure or appointment of officers or directors0001162194-20-000038
2020-04-2916:09 ET10-K/AAnnual report, amendedPeriod 2019-12-310001162194-20-000036
2020-04-2216:58 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001162194-20-000033
2020-04-1416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-002610
2020-03-0521:41 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-20-029390
2020-02-2717:10 ET10-KAnnual reportPeriod 2019-12-310001162194-20-000016
2020-02-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-000835
2020-01-1408:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-000218
2019-11-2216:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-066659
2019-11-0818:29 ET10-QQuarterly reportPeriod 2019-09-300001162194-19-000088
2019-11-0516:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-19-007184
2019-09-0617:15 ET8-K/A5.02 Departure or appointment of officers or directors0001171843-19-005845
2019-08-0717:18 ET10-QQuarterly reportPeriod 2019-06-300001162194-19-000068
2019-08-0206:05 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-19-005108
2019-08-0116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-19-005089
2019-07-2516:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-19-004882
2019-06-0516:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001171843-19-003846
2019-05-0717:28 ET10-QQuarterly reportPeriod 2019-03-310001162194-19-000033
2019-05-0216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-19-002872
2019-04-2416:05 ET8-K5.02 Departure or appointment of officers or directors0001171843-19-002590
2019-04-2317:14 ETDEF 14AProxy statementPeriod 2019-06-030001144204-19-020746
2019-04-0217:12 ETSC 13D/AOwnership report, active investor, amended0000921895-19-000979
2019-03-2216:05 ET8-K1.01 Entry into a material agreement0001171843-19-001916
2019-03-2017:24 ETSC 13D/AOwnership report, active investor, amended0000921895-19-000841
2019-03-1816:12 ET10-KAnnual reportPeriod 2018-12-310001162194-19-000020
2019-02-2806:06 ET8-K8.01 Other events0001171843-19-001302
2019-02-2116:45 ET8-K8.01 Other events0001171843-19-001104
2019-02-1416:10 ET8-K8.01 Other events0001171843-19-000933
2019-02-0716:28 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-19-000803
2018-12-1417:11 ETSC 13D/AOwnership report, active investor, amended0000921895-18-003309
2018-12-1217:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-347891
2018-11-0616:27 ET10-QQuarterly reportPeriod 2018-09-300001162194-18-000104
2018-11-0116:33 ETSC 13D/AOwnership report, active investor, amended0000921895-18-002903
2018-11-0116:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-007475
2018-10-3108:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-18-007394
2018-09-2016:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-18-006650
2018-08-0818:54 ET10-QQuarterly reportPeriod 2018-06-300001162194-18-000089
2018-08-0216:08 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001171843-18-005695
2018-08-0216:07 ET8-K5.02 Departure or appointment of officers or directors0001171843-18-005694
2018-08-0216:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-005693
2018-06-1514:45 ETSC 13D/AOwnership report, active investor, amended0000921895-18-001934
2018-06-0116:33 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure0001171843-18-004371
2018-05-0817:12 ET10-QQuarterly reportPeriod 2018-03-310001162194-18-000055
2018-05-0316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-18-003458
2018-04-2708:30 ETDEF 14AProxy statementPeriod 2018-05-310001144204-18-022867
2018-03-1917:22 ET8-K5.02 Departure or appointment of officers or directors0001171843-18-002086
2018-03-1307:45 ET8-K2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-18-001882
2018-03-0816:22 ET10-KAnnual reportPeriod 2017-12-310001162194-18-000032
2018-03-0617:19 ETSC 13D/AOwnership report, active investor, amended0000921895-18-000856

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.